AUVI-Q® (epinephrine injection, USP) is indicated in the
emergency treatment of allergic reactions (Type I) including anaphylaxis
to allergens, idiopathic and exercise-induced anaphylaxis. AUVI-Q is
intended for patients with a history of anaphylactic reactions or who are
at increased risk for anaphylaxis.
Important Safety Information
AUVI-Q is intended for immediate self-administration as emergency supportive
therapy only and is not a substitute for immediate medical care.
In conjunction with the administration of epinephrine, the patient should
seek immediate medical or hospital care.
Each AUVI-Q contains a single dose of epinephrine for single-use injection.
More than two sequential doses of epinephrine should only be administered
under direct medical supervision. Since the doses of epinephrine delivered
from AUVI-Q are fixed, consider using other forms of injectable epinephrine
if doses lower than 0.1 mg are deemed necessary.
AUVI-Q should ONLY be injected into the anterolateral aspect of the
thigh. Do not inject intravenously, or into buttock, digits, hands, or feet.
Instruct caregivers to hold the leg of young children and infants firmly in
place and limit movement prior to and during injection to minimize the risk
of injection-related injury.
Rare cases of serious skin and soft tissue infections have been reported
following epinephrine injection. Advise patients to seek medical care if
they develop any of the following symptoms at an injection site: redness
that does not go away, swelling, tenderness, or the area feels warm to the
Epinephrine should be administered with caution to patients with certain
heart diseases, and in patients who are on medications that may sensitize
the heart to arrhythmias, because it may precipitate or aggravate angina
pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal
ventricular fibrillation, have been reported in patients with underlying
cardiac disease or taking cardiac glycosides or diuretics. Patients with
certain medical conditions or who take certain medications for allergies,
depression, thyroid disorders, diabetes, and hypertension, may be at greater
risk for adverse reactions. Common adverse reactions to epinephrine include
anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness,
sweating, palpitations, pallor, nausea and vomiting, headache, and/or
Please see the full
You are encouraged to report negative side effects of prescription drugs to
the FDA. Visit
or call 1-800-FDA-1088.
Terms and Conditions
Only valid for commercially insured patients in the 50 United States and
DC through the direct delivery service and/or designated retail
pharmacies. Limit one (1) carton of AUVI-q 0.1 mg per patient each
calendar year. Limit two (2) cartons of AUVI-Q 0.15 mg or 0.3 mg per
patient each calendar year. Individual insurance companies and pharmacies
vary and may impose additional requirements that affect the timing and/or
redemption of the offer. Not eligible if prescriptions are paid for in
part/full by state or federally funded program(s), like Medicare Part D,
Medicaid, Vet. Aff., Dept. of Def., or Tricare, and where prohibited by
law. OFFER IS NOT INSURANCE. Offer cannot be sold, purchased, traded,
transferred, and cannot be combined with any other offer. Cash discount
cards are not commercial payers and are not eligible to be used for this
program. Offer provided by kaléo, and it may change at any time without
Call 844-357-3968 for questions
regarding offer eligibility.